ENLV
Enlivex Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$0.81
+10.92%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 0.00x
- PEG TTM
- —
- Price / book
- 0.01x
- Price / sales
- —
- Price / cash flow
- -1.32x
Enterprise value
- Enterprise value
- $8.9M
- EV / sales
- —
- EV / EBITDA
- -0.62x
- EV / EBIT
- -0.59x
- Market cap
- $14.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025